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A B S T R A C T
Background
Asmedical care becomes more complex and the ability to test for conditions grows, pressure on healthcare providers to convey increasing
volumes of test results to patients is driving investigation of alternative technological solutions for their delivery. This review addresses
the use of email for communicating results of diagnostic medical investigations to patients.
Objectives
To assess the effects of using email for communicating results of diagnostic medical investigations to patients, compared to SMS/ text
messaging, telephone communication or usual care, on outcomes, including harms, for health professionals, patients and caregivers,
and health services.
Search methods
We searched: the Cochrane Consumers and Communication Review Group Specialised Register, Cochrane Central Register of Con-
trolled Trials (CENTRAL, The Cochrane Library, Issue 1 2010), MEDLINE (OvidSP) (1950 to January 2010), EMBASE (OvidSP)
(1980 to January 2010), PsycINFO (OvidSP) (1967 to January 2010), CINAHL (EbscoHOST) (1982 to February 2010), and ERIC
(CSA) (1965 to January 2010). We searched grey literature: theses/dissertation repositories, trials registers and Google Scholar (searched
July 2010). We used additional search methods: examining reference lists and contacting authors.
Selection criteria
Randomised controlled trials, quasi-randomised trials, controlled before and after studies and interrupted time series studies of inter-
ventions using email for communicating results of any diagnostic medical investigations to patients, and taking the form of 1) unsecured
email 2) secure email or 3) web messaging. All healthcare professionals, patients and caregivers in all settings were considered.
Data collection and analysis
Two review authors independently assessed the titles and abstracts of retrieved citations. No studies were identified for inclusion.
Consequently, no data collection or analysis was possible.
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Main results
No studies met the inclusion criteria, therefore there are no results to report on the use of email for communicating results of diagnostic
medical investigations to patients.
Authors’ conclusions
In the absence of included studies, we can draw no conclusions on the effects of using email for communicating results of diagnostic
medical investigations to patients, and thus no recommendations for practice can be stipulated. Further well-designed research should
be conducted to inform practice and policy for communicating patient results via email, as this is a developing area.
P L A I N L A N G U A G E S U M M A R Y
The effects of using email to send test results to patients
Asmedical care becomes more complex and the ability to test for conditions grows, pressure on healthcare providers to convey increasing
volumes of test results to patients is leading to consideration of different ways to deliver the results to patients.This review searched
for high-quality research studies to try to determine how effective sending test results via email to patients or caregivers is, and what
the outcomes are for patients/caregivers, healthcare professionals and health services. We found no studies that looked at the effects of
using email for sending test results to patients, and so cannot present any results. We recommend that high-quality research is carried
out to examine the use of email for this purpose.
B A C K G R O U N D
Related systematic reviews
This review forms part of a suite of reviews, incorporating four
other reviews:
• email for the coordination of healthcare appointments and
attendance reminders (Atherton 2012);
• email for the provision of information on disease
prevention and health promotion (Atherton 2009a);
• email for clinical communication between patients/
caregivers and healthcare professionals (Atherton 2009c); and
• email for clinical communication between healthcare
professionals (Atherton 2009b).
The use of email
Email is easy to use, widely available internationally and inexpen-
sive. It is used in many areas of life, including banking, travel
and retail. Despite the ubiquity of email in day-to-day life and
in other sectors of the economy, its use in the healthcare sector
is still not routine (Neville 2004; Dixon 2010) although it is in-
creasing. Factors driving the trend of increasing email use include:
the natural demographic shift towards an increasing proportion of
people comfortable with using technology-driven care solutions;
and higher demands on healthcare resources with, for instance,
the advent of increased chronic care and demand for more pre-
ventive screening, resulting in a focus on working more efficiently
(OECD 2006).
Where email communication has been demonstrated in healthcare
settings, it is used for requesting prescriptions, booking appoint-
ments and for clinical consultation (Kleiner 2002; Gaster 2003;
Kittler 2004; Neville 2004; Castren 2005; Anand 2005).
Email for communicating results of diagnostic medical
investigations to patients
This review considered the use of email for delivering to patients
the results of diagnostic investigations, such as radiological exami-
nations and blood tests. Email is not suitable for all forms of com-
munication, such as where negotiation or uncertainty is involved,
but it has been shown to be a sound communication medium
for the purposes of requesting or delivering factual information
(Fridsma 1994).
Of the potential applications of email in health care, patients
have cited the communication of results as one they are keen to
see implemented (Neill 1994; Couchman 2001; Goldman 2006).
Clinicians have also mirrored this desire (although to a lesser ex-
tent), particularly for sending out normal results (Goodyear-Smith
2005).
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Advantages and disadvantages
The key advantages of using email for communicating results of
diagnostic medical investigations include the following (adapted
from Freed 2003; Car 2004a).
• Timely and low cost delivery of information (relative to
conventional mail) (Houston 2003).
• Convenience; emails can be sent and subsequently read at
an opportune time, outside of traditional office hours where
convenient (Neville 2004; Leong 2005).
• The ability to automate the generation of a frequently-used
results message.
• The capacity to place hyperlinks to appropriate educational
material in an email.
• Email addresses usually stay constant when an address or
telephone number changes (Virji 2006), making it a more
reliable way of maintaining communication with transient
patients.
• ’Read receipts’ can be used to confirm that communications
have been received.
• Relative to oral communication, the written nature of the
communication can be valuable as reference for the recipient,
aiding recall and providing evidence of the exchange (Car 2004a;
Car 2004b).
• Emails can be archived in online or offline folders separate
from the inbox of the email account so that they do not use up
space in the inbox but can be kept for reference (Car 2004a; Car
2004b).
• Patients may feel that email is a more intimate, direct
communication method than the telephone (Katz 2003).
There are, however, some potential downsides such as the follow-
ing:
• There is evidence of patient and physician concerns
regarding privacy, confidentiality and potential for the misuse of
information (Fridsma 1994; Harris 2001; Kleiner 2002; Moyer
2002; Katzen 2005).
• Physicians are wary of the potential for email systems to
generate an increased workload (Mandl 1998; Podichetty 2004).
• It may be difficult for practices to recover implementation
and other associated costs (especially in fee-for-service healthcare
systems) (Mandl 1998).
• Medico-legal issues may exist (including around informed
consent and use of non-encrypted email) (Bitter 2000).
• There is the potential to widen health inequalities via the
digital divide. As new technologies replace old systems, it has
been suggested that certain sectors of the population are being
left behind with regard to access and use of these services, such as
the elderly, non-English speakers and those in lower income
groups (Kleiner 2002; Katz 2004b; Goodyear-Smith 2005; Virji
2006).
• Technological issues may occur, such as recipients having a
full mailbox causing email to bounce back to the sender (Virji
2006).
• Systems may be at risk of failures, such as a loss of the link
to a central server (a computer which provides services used by
other computers, such as email) (Car 2008a). There may be
several causes of technological system failure; from local power
failure to natural disasters.
• There is a potential for human error which can lead to
unintended content or incorrect recipients.
Quality and safety issues
The main quality and safety issues around using email commu-
nication for results communication have included confidentiality,
potential for errors and ensuing liability, securing payment, in-
corporating email into existing work patterns and achievable costs
(Moyer 1999; Kleiner 2002; Gaster 2003; Gordon 2003; Hobbs
2003; Houston 2003; Car 2004b).
Privacy and confidentiality are a formidable challenge in the adop-
tion of email communication (Car 2004b; Katz 2004a). Patients
are more likely to use this type of communication if they have
access to the Internet from home, rather than from work, because
of privacy issues (Fridsma 1994). Family email accounts can mean
a lack of privacy (Mandl 1998). Web messaging systems can ad-
dress issues around security and liability that are associated with
conventional email communication, since they offer encryption
capability and access controls (Liederman 2003). However not all
healthcare institutions are capable of providing such a facility and
instead rely on standard mail (Car 2004b).
Medico-legal issues are of substantial concern when implementing
email communication in practice. These include potential liability
for security breaches allowing a third party to access confidential
medical information, and the possibility of identity fraud whereby
someone poses as a patient to obtain private information (Moyer
1999; Couchman 2001; Car 2004b). Suggestions for minimising
the legal risks of using email in practice have included: adherence to
the same strict data protection rules that must be followed in busi-
ness and industry; adequate infrastructure to provide encrypted,
secure email transit and storage; and the use of informed consent to
ensure that the patient is aware of the risks and benefits associated
with receiving diagnostic medical results via email (Car 2004b).
Obtaining informed consent could include the provision of guide-
lines to patients about the use of email communication, and pro-
vide an opportunity for authentication of identity. Authentication
of patient identity can be achieved by routinely validating patient
email addresses when email communication commences. Ongo-
ing validation of identity has also been recommended (Medem
2007).
Patient opinion of such systems is also important. Issues facing
service users have included questionable reliability, timeliness and
the impersonal nature of email (Katz 2003). There is already evi-
dence for patients having diverse preferences about receiving their
diagnostic test results (Couchman 2005). For example, there may
be a strong case for using email to deliver good news where no
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consultation is required (such as a negative chlamydia screening
result). Complex messages, such as an inconclusive chest x-ray,
may not be suitable for email communication.
Such issues are wide ranging and encompass both healthcare pro-
fessional and patient perspectives.We planned to identify all issues
of quality and safety arising in the included studies. The review is
both timely and necessary, since the email delivery of diagnostic
test results is in its infancy, and is developing in a non-uniform
fashion in the absence of clear evidence of its efficacy, safety and
acceptability.
Forms of electronic mail
In the absence of a standardised email communication infrastruc-
ture in the healthcare sector, email has been adopted in an ad-hoc
fashion and this has included the use of unsecured and secured
email communication.
Standard unsecured email is email which is sent unencrypted. Se-
cured email is encrypted; encryption transforms the text into an
un-interpretable format as it is transferred across the Internet. En-
cryption protects the confidentiality of the data, however both
sender and recipient must have the appropriate software for en-
cryption and decoding (TechWeb Network 2008).
Secure email also includes various specifically developed applica-
tions such as patient portals which utilise web messaging. Such
portals provide pro-formas into which patients can enter their
message. The message is sent to the recipient in the manner of an
email (TechWeb Network 2008).
Secure websites are distributed by secure web servers. Web servers
store anddisseminatewebpages. Secure servers ensure data froman
Internet browser is encrypted before beinguploaded to the relevant
website. This makes it difficult for the data to be intercepted and
deciphered (TechWeb Network 2008).
There are significant differences in terms of these applications.
Bespoke secure email programmesmay incorporate special features
such as standard forms guiding the use and content of the email
sent, the capacity to show read receipts (in order to confirm the
patient has received the correspondence) and, if necessary, facilities
for receiving payment (Liederman 2005). However they are costly
to set up and may require a greater degree of skill on the part of the
user than standard unsecured email (Katz 2004b). For the purpose
of the review all methods are included, although secured versus
unsecured email would be considered in a subgroup analysis.
Methods of accessing email
Methods of accessing the Internet and thus an email account have
changedwith time. Traditionally, access would occur via a personal
computer or laptop at home or work, connecting to the Internet
using a fixed line. There are now several methods of accessing
the Internet. Wireless networks (known colloquially as wifi) allow
Internet connection to a personal computer, laptop computer or
other device wherever a network is available (TechWeb Network
2008). Internet connection is also possible via alternative networks
using mobile devices. This includes access via mobile telephones
to a wireless application protocol (WAP) network (rather than to
the world wide web) or to the third generation (3G) network.
Adaptors connecting to a universal serial bus (USB) port can be
used to access the 3G network using a laptop computer (TechWeb
Network 2008). Therefore email can be accessed away from the
office or home in a variety of ways.
For the purposes of the review we included all methods of email
access.
O B J E C T I V E S
To assess the effects of using email for communicating results of di-
agnostic medical investigations to patients compared to SMS/ text
messaging, telephone communication or usual care, on outcomes,
including harms, for health professionals, patients and caregivers,
and health services.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs), quasi-ran-
domised trials, controlled before and after studies (CBAs) with at
least two intervention and two control sites, and interrupted time
series (ITS) with at least three time points before and after the
intervention.
Due to the practicalities of organisational change in a healthcare
environment, most studies are not randomised and therefore we
considered quasi-randomised trials and CBAs. The inclusion of
ITS is particularly valuable in assessing the ongoingmerits of a new
technology which may required a ’settling in’ period. We included
trials with individual and cluster randomisation, and relevant trials
with economic evaluations.
Types of participants
We considered healthcare professionals, associated administrative
staff, patients and caregivers regardless of age, gender and ethnic-
ity. We included studies in all settings, i.e. primary care settings
(services of primary health care), outpatients settings (outpatient
clinics), community settings and hospital settings. We did not ex-
clude studies according to the type of healthcare professional (e.g.
surgeon, nurse, doctor, allied staff ).
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We considered participants originating the email communication,
receiving the email communication and copied into the email
communication.
Types of interventions
We included interventions using email for communicating results
of any diagnostic medical investigations to patients.
We considered interventions that used email in any of the follow-
ing three forms:
1. Unsecured standard email to/from a standard email
account.
2. Secure email which is encrypted in transit and sent to/from
a standard email account with the appropriate decoding software.
3. Web messaging, whereby the message is entered into a pro-
forma which is sent to a specific email account, the address of
which is not available to the sender.
We included all methods of accessing email, including broadband
via a fixed line, broadband via a wireless connection, connecting
to the 3G network and connecting to the WAP network.
Studies in which email was part of a multifaceted intervention
were included where the effects were individually reported, even
if they did not represent the primary outcome, but only if they
achieved the appropriate statistical power. Where this could not
be determined, or where it was not possible to separate the effects,
we excluded these studies.
We included studies comparing the intervention to no interven-
tion, as well those comparing it to other modes of communication
such as face-to-face, postal letters, calls to a landline or mobile
telephone, text messaging using a mobile telephone, and if appli-
cable, automated versus personal emails.
We excluded mobile phone text messaging for communicating
results, which is the subject of a separate Cochrane review (Gurol-
Urganci 2012).
We excluded trials which considered the general use of email
for healthcare professional-patient contact for multiple purposes,
where communicating the results of diagnostic medical investiga-
tions was included but not separately evaluated.
Types of outcome measures
Primary outcomes of interest focused on whether the email has
been understood and acted upon correctly by the recipient as in-
tended by the sender, and secondary outcomes focused on whether
email was an appropriate mode for the communication exchange.
Primary outcomes
Healthcare professional outcomes resulting from whether the email
has been understood and acted upon correctly by the recipient
(patient) as intended by the sender (professional), e.g. professional
knowledge and understanding, professional behaviour, actions or
performance.
Patient outcomes associated with whether the email has been un-
derstood and acted upon correctly by the recipient as intended by
the sender, e.g. patient understanding, clinical progression, treat-
ment outcomes, patient health status and well-being, patient be-
haviours or actions (such as making requested follow-up appoint-
ments).
Health service outcomes associatedwithwhether the email has been
understood and acted upon correctly by the recipient as intended
by the sender, e.g. service use, management or coordination of
health problem.
Harms e.g. effects on safety or quality of care, breaches in privacy,
technology failures.
Secondary outcomes
Professional, patient or carer outcomes associated with whether
email was an appropriate mode for the communication exchange,
e.g. knowledge and understanding, effects on professional-patient
or professional-carer communication or relationship, evaluations
of care (such as convenience, timeliness, acceptability, satisfaction).
Health service outcomes associated with whether email was an ap-
propriate mode for the communication exchange, e.g. use of re-
sources or time, costs.
Search methods for identification of studies
Electronic searches
We searched the following electronic bibliographic databases.
• Cochrane Consumers and Communication Review Group
Specialised Register (searched 8 January 2010)
• Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, Issue 1 2010)
• MEDLINE (OvidSP) (1950 to 5 January 2010)
• EMBASE (OvidSP) (1980 to 7 January 2010)
• PsycINFO (OvidSP) (1967 to 5 January 05/01/2010)
• CINAHL (EbscoHOST) (1982 to 2 February 2010)
• ERIC (CSA) (1965 to 7 January 2010)
We present detailed search strategies in Appendices 2 to 7. John
Kis-Rigo, Trials Search Coordinator for the Cochrane Consumers
and Communication Group compiled the strategies.
There were no language or date restrictions.
Searching other resources
Grey literature
We searched for grey literature, and ongoing and recently com-
pleted studies, in July 2010, using the following sources:
5Email for communicating results of diagnostic medical investigations to patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• Australasian Digital Theses Program (http://
adt.caul.edu.au/)
• Networked Digital Library of Theses and Dissertations
(http://www.ndltd.org)
• UMI ProQuest Digital Dissertations (http://
wwwlib.umi.com/dissertations/)
• Index to Theses (http://www.theses.com/) (Great Britain
and Ireland)
• Clinical trials register (Clinicaltrials.gov)
• WHO Clinical Trial Search Portal (www.who.int/
trialsearch)
• Current Controlled Trials (www.controlled-trials.com)
• Google Scholar (http://scholar.google.co.uk/) (we examined
the first 500 hits)
We searched databases from their start date and there were no
limitations by language. We kept detailed records of all the search
strategies applied.
Reference lists
We examined the reference lists of retrieved relevant studies.
Correspondence
We contacted the authors of included studies across all five reviews
(Atherton 2009a; Atherton 2009b; Atherton 2009c; Atherton
2012) for advice as to any further studies or unpublished data that
they were aware of. Many of the authors of these included studies
were also experts in the field.
Data collection and analysis
Selection of studies
Two review authors (HA and PS) independently assessed the po-
tential relevance of all titles and abstracts identified from electronic
searches. We retrieved full text copies of all articles judged to be
potentially relevant. BothHA andPS independently assessed these
retrieved articles for inclusion. Where HA and PS could not reach
consensus a third author, JC, examined these articles. During a
meeting of all review authors we verified that there were no in-
cluded studies in the review.
Data extraction and management
Themethods that wewould have applied hadwe found any studies
are outlined in Appendix 1 and will be applied to future updates
of the review.
Consumer input
We asked two consumers, a health services researcher (UK) and
healthcare consultant (Saudi Arabia) to comment on the com-
pleted reviews (all five email reviews) before submitting each for the
peer-review process, with a view to obtaining feedback on the ap-
plicability of the review to potential users. The review also received
feedback from two consumer referees as part of theCochraneCon-
sumers and Communication Review Group’s standard editorial
process.
R E S U L T S
Description of studies
Results of the search
As this review was one in a set of five looking at varying uses
of email in healthcare, we conducted a common search for all
five reviews (Atherton 2009a; Atherton 2009b; Atherton 2009c;
Atherton2012). Relevant articles were allocated to the appropriate
review after being assessed at the full text stage. Figure 1 illustrates
the various stages of the search.
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Figure 1. Flow diagram illustrating search results.
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Included studies
For this review, we identified no studies meeting the inclusion
criteria.
Risk of bias in included studies
There were no included studies.
Effects of interventions
There were no included studies.
D I S C U S S I O N
Summary of main results
We found no studies specifically evaluating the use of email to
sending test results, despite this being a feature patients were keen
to see implemented (Couchman 2001).
Unlike interventions with a directly-measurable impact on health
(drug treatments, surgical procedures), email is a complex inter-
vention and its potential impact may come from any number of
factors. A complex intervention is one that has several interact-
ing components (Craig 2008). The complexity can have several
dimensions; these may include the organisational levels targeted
by the intervention (administrative staff, nurses, doctors, manage-
ment) or degree of flexibility or tailoring of the intervention per-
mitted (standard email allowing free text, web-based systems with
a pro-forma for entering text). As a consequence of this complexity
it may be more difficult to determine what should be tested and
how, and doing this in the context of a controlled trial may be
perceived as difficult. We included other types of study designs as
well as randomised controlled trials in this review, but none of the
listed study designs were identified.
Overall completeness and applicability of
evidence
Possible reasons for the lack of included studies may be that email-
ing diagnostic results to patients comes under the more general
category of administrative purposes for email (e.g. scheduling ap-
pointments, medication requests or test results) or features as
part of generic patient- physician communication systems. In the
linked review (Atherton 2009c) of email for communication be-
tween patients/caregivers and healthcare professionals, systems set
up to facilitate email communication between patients/caregivers
and healthcare professionals were used by some patients to enquire
about test results and their implications, rather than being used by
physicians for sending results to patients However, these studies
did not meet the inclusion criteria for this review (Katz 2004b;
Kummervold 2004; Lin 2005; Ross 2004; Stalberg 2008).
The idea of communicating results of diagnostic medical investi-
gations featuring as part of a general patient-physician communi-
cation system is considered in studies by various US health sys-
tem organisations. Kaiser Permanente analysed data collected via
their integrated electronic health record system on the use of email
between physician and patients, and this system included provi-
sion of laboratory test results (Zhou 2010). Geisinger, another US
health system organisation, conducted an online survey of patients
using their patient portal for messaging their healthcare provider,
and a function of this portal was the ability for patients to view
their 25 most frequently-ordered laboratory tests, with an expla-
nation of the results (Hassol 2004). Both of these organisations
utilised systems already in place in the form of integrated elec-
tronic healthcare records to carry out their research, rather than
conducting trials. Zhou 2010 stated that they “could not conduct
a randomized controlled trial; the system architecture and imple-
mentation schedules of the patient portal precluded it” and that
they were unable to “assess the effect of secure patient-physician
e-mail independent of other functionalities of the portal, includ-
ing lab test results.” Other organisations in the US (Abbott 2002;
Adamson 2010) and across the world have carried out similar re-
search on existing systems that have multiple functions (Neville
2004) such as provision of test results.
Practice for advising patients of their diagnostic test results varies
between clinicians (Boohaker 1996). Itmay be difficult to establish
the overall benefits of any particular method where there is a wide
variability in the proportion of telephone transmission/ postal re-
sults as well as in the proportion of results proactively reported to
patients. Some practices have a policy of ’no news is good news’,
by which the patient should assume that if the result is not com-
municated, the result was normal. There are inherent concerns
with this strategy, such as the lack of safety netting. Additionally,
sending results via email could result in increased workloads (al-
beit that practices may be meeting previously unmet patient need)
(Keren 2003). No single method is suitable for conveying all types
of test result, as they have different requirements in terms of ur-
gency and complexity of the message to be delivered. As almost
all practices use a combination of methods, and email is likely to
provide a complementary option to the current methods, simple
studies comparing efficiency of email versus telephone are likely to
be somewhat artificial. The suitability of email would largely de-
pend on the complexity and urgency of the result. It may be more
useful to study specific types of test result, e.g. negative chlamydia
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screening, to establish whether results were adequately understood
in a confidential, cost-effective and timely fashion when compared
to alternative methods of receiving the same information.
Finally, it is possible that trials have been conducted that are not
available in the literature, having found inconclusive or negative
benefits of new system developments which may be commercial
ventures. Such possible publication biases should be discouraged
by use of trial registration, though this is more difficult where
commercial organisations drive research.
Quality of the evidence
The search for this review was conducted in January 2010. The
length of time that has elapsed between the search date and the
publication of this review means that it is possible that relevant
studies have been published in the interim period. To counter this,
we will update the review in the near future.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
No recommendations for practice can be made given the cur-
rent lack of evidence of benefit (or harm). This is unfortunate,
given the burgeoning requirements for patient testing in the ar-
eas of health screening e.g. cholesterol, diabetes, renal function
and sexual health screening (Swartzendruber 2010; Khunti 2011).
Healthcare workers need to examine more efficient patterns of
working to keep up with increased per capita healthcare demands
(OECD 2006). With ever growing internet access, email usage
and technological familiarity in the general population, email pro-
vides an obvious mechanism for the transmission of results.
Implications for research
This review highlights the need for randomised controlled trials
to evaluate the effects of using email for communicating results
of diagnostic medical investigations to patients. Future trials need
to be rigorous in design and delivery, with reporting to include
high-quality descriptions of all aspects of methodology to enable
appraisal and interpretationof results. Prompting the development
of such trials may involve addressing barriers to trial development
and implementation, including funding and time.
Well-designed randomised controlled trials or controlled before
and after studies are needed to ascertain if email will be an ef-
fective, safe and secure medium for transmission of results. Trials
would benefit from initially focusing on diagnostic tests that lead
to a clearly understood results e.g. a normal pap smear or normal
prostate specific antigen (PSA) test result (Katz 2004b). In a sur-
vey of patient and physicians, these were some the types of tests
that were selected as being the most appropriate for transmission
via email. As the complexity of the message increases and the need
for negotiation of meaning between patient and healthcare pro-
fessional grows, it seems less likely that email would be suitable. It
would require supplementary/additional clinic or telephone con-
sultation (Katz 2004b). For example, abnormal PSA results present
a much greater challenge to practitioners in conveying the non-
specific nature of the test and its possible interpretations.
Factors to consider are successful receipt of message and time to re-
ceipt compared to current standard practice of telephone or postal
communications. Some authors (Freed 2003; Car 2008a) have
suggested that the use of email communications may be transfor-
mational, and as such unexpected outcomes and consequences of
this new use of technology may occur. For instance the effect of
email on the patient-physician relationshipmay be difficult to cap-
ture in quantitative research formats. Qualitative research meth-
ods may provide a deeper insight into issues raised by the use of
email to provide patients with test results. These issues may, for
example, relate to patient satisfaction.
The chosen study design should allow for analysis of possible vari-
ation of effect by patient group, especially by income, education
and age. A concern often cited by both patients and physicians is
the security of email messaging (Car 2004b) and so this should
be addressed specifically to allay or confirm fears which may be
influencing its use. Additionally, while postal mail is traditionally
considered a more secure method, the robustness of this assertion
should be proven as there are numerous potential problems with
postal mail including use of an incorrect address or mail being
opened by another family member.
Workload concerns have been raised by healthcare staff in relation
to email, and future studies should assess the impact of email for
results communication on the volume of telephone communica-
tions and on follow-up consultations. Katz 2004b notes that more
sensitive measures of workload unit should be developed to allow a
more accurate measurement of the impact of email for communi-
cation. The costs of email have reduced in recent years owing to its
ubiquity, and its scaleable nature means that costs do not increase
as rapidly with larger numbers of patients as with other methods of
communication. Therefore economic assessments should be un-
dertaken where possible.
Outcomes to be assessed by future studies may feature those pre-
dominately relating to email, such as its usability, security and im-
pact on healthcare professionals’ workload. However it may also
assess factors that arise as a consequence of the nature of email:
the personal communication it can allow, its two-way nature and
the capacity to retain a copy of the information sent/received.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Methods for application in future updates
We outline below the methods to be applied in any future updates of this review, should studies be identified for inclusion.
Data extraction and management
Wewill extract data from all included studies using a standard form derived from the data extraction template provided by the Cochrane
Consumers and Communication Review Group. We will extract the following data:
• General information: Title, authors, source, publication status, date published, language, review author information, date
reviewed.
• Details of study: Aim of intervention and study, study design, location and details of setting, methods of recruitment of
participants, inclusion/exclusion criteria, ethical approval and informed consent, consumer involvement.
• Assessment of study quality: Key features of allocation, contemporaneous data collection for intervention and control groups; and
for interrupted time series, number of data points collected before and after the intervention, follow-up of participants.
• Risk of bias: data to be extracted depends on study design (see Assessment of risk of bias in included studies).
• Participants: Description, geographical location, setting, number screened, number randomised, number completing the study,
age, gender, ethnicity, socio-economic grouping and other baseline characteristics, test requested, diagnosis, treatment.
• Health service: description, geographical location, setting, age, gender, population served, medical setting and clinical context of
patients.
• Intervention: Description of the intervention and control including rationale for intervention versus the control (usual care).
Delivery of the intervention including email type (standard unsecured email, secure email, web portal or hybrid). Type of clinical
information communicated. Content of communication (e.g. text, image). Purpose of communication (e.g. obtaining information,
providing information). Communication protocols in place. Who delivers the intervention (e.g. healthcare professional,
administrative staff ). How consumers of interventions are identified. Sender of first communication (health service, professional,
patient and/or carer). Recipients of first communication (health service, professional, patient and/or carer). Whether the
communication invites a response (content, frequency). Any co-interventions included. Duration of intervention. Quality of
intervention. Follow up period and rationale for chosen period.
• Outcomes: principal and secondary outcomes, methods for measuring outcomes, methods of follow-up, tools used to measure
outcomes, whether the outcome is validated.
• Results: for outcomes and timing of outcome assessment, control and intervention groups if applicable.
The data extraction template will be piloted to allow for unforeseen variations in studies. For every included study at least two review
authors will independently perform the data extraction. Any discrepancies between the review authors’ data extraction sheets will be
discussed and resolved, though where necessary; we will involve another review author to resolve discrepancies.
Assessment of risk of bias in included studies
Two review authors will independently assess the quality of included studies, with any disagreements resolved by discussion and
consensus, and by consulting a third author where necessary. Studies of different designs will be dealt with separately throughout this
review in both the quality assessment and analysis.
For RCTs (and quasi RCTs), we will assess and report on the following elements that contribute to bias, according to the guidelines
outlined in Higgins 2008:
• Sequence generation;
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• Allocation concealment;
• Blinding (participants, personnel, outcomes assessors, data analysers);
• Intention-to-treat analysis;
• Incomplete outcome data;
• Selective outcome reporting.
We will describe the study and assign a judgement relating to the risk of bias for each item. We would use a template to guide the
assessment of risk of bias, based upon the guidance by Higgins 2008, judging each item as ‘yes’ (indicating a low risk of bias), ‘no’
(indicating a high risk of bias) or ‘unclear’ (indicating an uncertain risk of bias). For each study we will summarise the risk of bias for
each outcome.
We will also assess a range of other possible sources of bias and indicators of study quality, in accordance with the guidelines of the
Cochrane Consumers and Communication Review Group (Ryan 2007), including:
• Baseline comparability of groups;
• Validation of outcome assessment tools;
• Reliability of outcome measures;
• Other possible sources of bias
In the case of studies other than RCTs being identified (that is, quasi-randomised controlled trials, CBA and ITS studies) we will
additionally assess the quality of these studies systematically and according to the criteria outlined in the guidelines of the Cochrane
Consumers and Communication Review Group so that risk of bias may be ascertained.
We will present the results of the risk of bias assessment in tables and incorporating the results of the assessment of risk of bias into the
review through systematic narrative description and commentary about each of the quality items, for each type of included study. This
leads to an overall assessment of the risk of bias across the included studies and a judgement about the possible effects of bias on the
effect sizes of the included studies.
Where required, we will contact study authors for additional information about the included studies, or for clarification of the study
methods.
Measures of treatment effect
For continuous data, where outcomes have been measured in a standard way across studies, we will report the mean difference and
confidence intervals. For dichotomous data, when outcomes have been measured in a standard way, we will report the odds ratio/risk
ratio and confidence intervals.
Unit of analysis issues
Issues may arise from the inclusion of cluster-randomised trials, repeated measurements and studies with more than two treatment
groups. If applicable the data will be analysed according to recommendations in the Cochrane Collaboration Open Learning Module
on issues related to the unit of analysis (Alderson 2002).
Dealing with missing data
If data are missing from the relevant comparisons we will attempt to contact the authors of the studies to obtain the information. If the
authors cannot be reached, or if the studies are found to be unsatisfactory on the basis of data provided, these studies will be excluded.
Assessment of heterogeneity
Firstly, heterogeneity will be identified by visual inspection of forest plots. Where confidence intervals for individual studies have poor
overlap it generally indicates the presence of statistical heterogeneity.
Secondly, a standard Chi2 test will be used to formally test for the presence of statistical heterogeneity. Where a meta-analysis includes
studies with a small sample size or where studies are few in number the Chi2 test has low power. To allow for this a P value of 0.10 (rather
than 0.05) will be used to determine statistical significance. Though a significant result may indicate a problem with heterogeneity, a
non-significant result does not provide evidence of no heterogeneity.
As well as carrying out a Chi2 test, an I2 statistic will be used. The test assesses the impact of heterogeneity on the meta-analysis, rather
than simply testing whether heterogeneity is present. The I2 statistic quantifies inconsistency across the studies. It describes the % of
the variability in effect estimates that is due to heterogeneity rather than sampling error.
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The importance of the observed value of I2 depends on the magnitude and direction of effects, and the strength of the evidence for
heterogeneity (Chi2 test, confidence intervals for I2). Both the Chi2 value and the I2 value can be used together to assess the potential
statistical heterogeneity in a meta-analysis.
Where statistical heterogeneity is identified reasons for the heterogeneity will be sought by examining clinical and methodological
heterogeneity. These are assessed by comparing the included studies according to participants, interventions, outcomes and study
designs, by assessing the risk of bias and by examining subgroups. The level of statistical heterogeneity present will be taken into account
when choosing the method of analysis for the review.
Assessment of reporting biases
Where data in the review have been standardised and pooled funnel plots will be used to check for publication bias. Funnel plots are
produced using Review Manager 5 software.
In interpreting the funnel plot it is necessary to consider possible reasons for asymmetry other than publication bias and these might
include poor methodological design and sampling variation.
Data synthesis
Data synthesis will comprise a narrative overview of the findings. This would be followed by a quantitative meta-analysis if appropriate.
The decision to carry out a meta-analysis is dependent on the nature of the studies included in the review. The diversity between studies
according to clinical factors, comparisons and outcomes will be considered.
The decision is likely to depend upon the type of intervention and the outcome measures used in the study. Therefore studies should
be classified according to:
• Study design: RCTs, CBAs, ITS.
• Outcome measures used, as described under Types of outcome measures
The risk of bias in the included studies will also be considered. Where there is great diversity between studies, and/or a high risk of
bias, it is not necessarily appropriate to pool the data. A decision on whether to carry out a meta-analysis will made be according to
these factors and after discussion amongst study authors.
Where it is deemed appropriate to carry out a meta-analysis the choice of model will be influenced by the level of statistical heterogeneity
identified using both the Chi2 and I2 test.
A random-effects meta-analysis assumes that the studies are not all estimating the same intervention effect. It can be used to incorporate
heterogeneity among studies. It is not a substitute for a thorough investigationof heterogeneity and is intendedprimarily for heterogeneity
that cannot be explained. It provides a more conservative estimate of effect. A fixed-effect meta-analysis assumes that each study is
estimating exactly the same quantity and that any variation between the results of the studies is due to chance. It more precise than a
random-effects model, because in the presence of statistical heterogeneity it usually has narrower confidence intervals.
We will conduct the analysis according to Cochrane Handbook guidance (Higgins 2008).
Subgroup analysis and investigation of heterogeneity
Where relevant, subgroup analysis will allow the examination of the effect of certain studies on the pooled effects of the intervention.
1. Age
Consideration of the acceptability to different age groups (for both healthcare professionals and patients). This is important as there
is clear evidence that the use of email is predicted by age with a clear tailing off in the generation who have not grown up in the
digital age. It is therefore important to consider the intervention effect in the groups which are accustomed to the technology, since the
intervention is likely to become more generalisable to the population as it ages. This will be considered where the primary studies seek
to consider age group from the outset. We would have distributed patients into three age subgroups: 0 to 17, 18 to 64, over 65. The
choice of distribution was made on the basis of two surveys by The Pew Internet & American Life survey (Pew 2005).
2. Location
Location of the studies will also be considered, since differing environments may condition the accessibility of the technology. For
instance we might expect communication technologies and their accessibility to differ according to country and/or region, or according
to whether the study is set in a rural or urban area.
3. Type of email communication
Additionally we propose to analyse the results by method of electronic mail utilized e.g. standard email versus a secure web messaging
service where relevant.
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4. Year of Publication
Lastly we will consider results by year of publication, as those more recent studies may be more relevant given evidence of increasing
usage and therefore assumed acceptability.
Sensitivity analysis
Studies deemed to be of lower quality after examination of individual study characteristics and assessment of risk of bias will be removed
from the analysis to examine the effects of this on the pooled effects of the intervention.
We would exclude studies according to the following filters:
• Outlying studies after initial analysis.
• Largest studies.
• Unpublished studies.
• Language of publication.
• Source of funding (e.g. public versus industry).
Other possible considerations for sensitivity analysis would include different measures of effect size (risk difference, odds ratios).
Appendix 2. CENTRAL search strategy
#1 MeSH descriptor Electronic Mail, this term only
#2 (electronic-mail* or email* or e-mail* or web-mail* or webmail* or internet-mail* or mailing-list or discussion-list or
listserv*):ti,ab,kw
#3 (patient or health or information or web or internet) next portal
#4 patient next (web or internet)
#5 (web* or internet or www or electronic* or online or on-line) near (messag* or communicat* or transmi* or transfer* or
send* or deliver* or feedback or letter or interactiv* or input* or forum or appointment or booking or schedul* or remind*
or referral or consult* or prescri*)
#6 (online or on-line or web* or internet) near (service or intervention or therap* or treatment or counsel*)
#7 e-communication or e-consult* or e-visit or e-referral or e-booking or e-prescri*
#8 MeSH descriptor Computer Communication Networks, this term only
#9 (#8), from 1996 to 2002
#10 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #9)
#11 MeSH descriptor Physician-Patient Relations, this term only
#12 MeSH descriptor Professional-Patient Relations, this term only
#13 MeSH descriptor Interprofessional Relations, this term only
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(Continued)
#14 “doctor patient relation”:kw
#15 “interpersonal communication”:kw
#16 “human relation”:kw
#17 “patient counseling”:kw
#18 MeSH descriptor Telemedicine explode all trees
#19 telehealth or telemedicine or teleconsultation or telecommunication
#20 diagnostic-test or laboratory-test
#21 (#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20)
#22 internet:kw,ti
#23 (#21 AND #22)
#24 (#10 OR #23)
#25 (#24)…………….[in Clinical Trials]
Appendix 3. MEDLINE (OvidSP) search strategy
1. computer communication networks/
2. limit 1 to yr=“1996 - 2002”
3. electronic mail/
4. (electronic mail* or email* or e-mail* or web mail* or webmail* or Internet mail* or mailing list* or discussion list* or listserv*).tw.
5. ((patient or health or information or web or Internet) adj portal*).tw.
6. (patient adj (web* or internet)).tw.
7. ((web* or internet or www or electronic* or online) adj5 (messag* or communicat* or transmi* or transfer* or send* or deliver* or
feedback or letter* or interactiv* or input* or forum or appointment* or booking* or remind* or referral* or consult* or prescri*)).tw.
8. ((online or web* or internet) adj4 (service* or intervention* or therap* or treatment* or counsel*)).tw.
9. (e-communication* or e-consult* or e-visit* or e-referral* or e-booking* or e-prescri*).tw.
10. or/2-9
11. physician patient relations/
12. professional patient relations/
13. interprofessional relations/
14. remote consultation/
15. or/11-14
16. internet/
17. 15 and 16
18. 10 or 17
19. randomized controlled trial.pt.
20. controlled clinical trial.pt.
21. random*.tw.
17Email for communicating results of diagnostic medical investigations to patients (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
22. placebo*.tw.
23. drug therapy.fs.
24. trial.tw.
25. groups.tw.
26. clinical trial.pt.
27. evaluation studies.pt.
28. research design/
29. follow up studies/
30. prospective studies/
31. (control* or prospectiv* or volunteer*).tw.
32. cross over studies/
33. comparative study.pt.
34. experiment*.tw.
35. time series.tw.
36. (pre test or pretest or post test or posttest).tw.
37. (pre intervention or preintervention or post intervention or postintervention).tw.
38. (impact* or intervention* or chang*).tw.
39. effect?.tw.
40. or/19-39
41. exp animals/ not humans.sh.
42. 40 not 41
43. 18 and 42
Appendix 4. EMBASE (OvidSP) search strategy
1. e-mail/
2. (electronic mail* or email* or e-mail* or web mail* or webmail* or internet mail* or mailing list* or discussion list* or listserv*).tw.
3. ((patient or health or information or web or internet) adj portal*).tw.
4. (patient adj (web* or internet)).tw.
5. ((web* or internet or www or electronic* or online) adj5 (messag* or communicat* or transmi* or transfer* or send* or deliver* or
feedback or letter* or interactiv* or input* or forum or appointment* or booking* or scheduling or remind* or referral* or consult* or
prescri*)).tw.
6. ((online or web* or internet) adj4 (service* or intervention* or therap* or treatment* or counsel*)).tw.
7. (e-communication* or e-consult* or e-visit* or e-referral* or e-booking* or e-prescri*).tw.
8. or/1-7
9. doctor patient relation/
10. interpersonal communication/
11. human relation/
12. patient counseling/
13. exp telemedicine/
14. telecommunication/
15. exp diagnostic test/
16. or/9-15
17. internet/
18. 16 and 17
19. 8 or 18
20. randomized controlled trial/
21. single blind procedure/ or double blind procedure/
22. crossover procedure/
23. random*.tw.
24. trial.tw.
25. placebo*.tw.
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26. ((singl* or doubl*) adj (blind* or mask*)).tw.
27. (experiment* or intervention*).tw.
28. (pre test or pretest or post test or posttest).tw.
29. (preintervention or postintervention).tw.
30. (cross over or crossover or factorial* or latin square).tw.
31. (assign* or allocat* or volunteer*).tw.
32. (control* or compar* or prospectiv*).tw.
33. (impact* or effect? or chang* or evaluat*).tw.
34. time series.tw.
35. or/20-34
36. nonhuman/
37. 35 not 36
38. 19 and 37
Appendix 5. PsycINFO (OvidSP) search strategy
1. exp electronic communication/
2. (electronic mail* or email* or e-mail* or web mail* or webmail* or internet mail* or mailing list* or discussion list* or listserv*).tw.
3. ((patient or health or information or web or internet) adj portal*).tw.
4. (patient adj (web* or internet)).tw.
5. ((web* or internet or www or electronic* or online) adj5 (messag* or communicat* or transmi* or transfer* or send* or deliver* or
feedback or letter* or interactiv* or input* or forum or appointment* or booking* or schedul* or remind* or referral* or consult* or
prescri*)).tw.
6. ((online or web* or internet) adj4 (service* or intervention* or therap* or treatment* or counsel*)).tw.
7. online therapy/
8. (e-communication* or e-consult* or e-visit* or e-referral* or e-booking* or e-prescri*).tw.
9. or/1-8
10. exp therapeutic processes/
11. interpersonal communication/
12. telemedicine/
13. feedback/
14. or/10-13
15. internet/
16. exp internet usage/
17. 15 or 16
18. 14 and 17
19. 9 or 18
20. (“32” or “33” or “34”).cc.
21. (health* or medic* or patient* or clinic* or hospital* or illness* or disease* or disorder* or therap* or physician* or doctor* or
psychotherap* or psychiatr* or telemedic* or treatment* or consult* or counsel* or referral* or remind* or appointment* or booking*
or schedul* or visit* or prescri* or promot* or prevent* or diagnos* or test result* or screen* or intervention* or care).ti,ab,hw,id.
22. 20 or 21
23. 19 and 22
24. random*.ti,ab,hw,id.
25. (experiment* or intervention*).ti,ab,hw,id.
26. trial*.ti,ab,hw,id.
27. placebo*.ti,ab,hw,id.
28. groups.ab.
29. ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).ti,ab,hw,id.
30. (pre test or pretest or post test or posttest).ti,ab,hw,id.
31. (preintervention or postintervention).ti,ab,hw,id.
32. (cross over or crossover or factorial* or latin square).ti,ab,hw,id.
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33. (assign* or allocat* or volunteer*).ti,ab,hw,id.
34. (control* or compar* or prospectiv*).ti,ab,hw,id.
35. (impact* or effect? or chang* or evaluat*).ti,ab,hw,id.
36. time series.ti,ab,hw,id.
37. exp experimental design/
38. (“0430” or “0450” or “0451” or “1800” or “2000”).md.
39. or/24-38
40. limit 39 to human
41. 23 and 40
Appendix 6. CINAHL (EbscoHOST) search strategy
Search conducted by Cochrane Consumers & Communication Review Group and results sent to us.
Appendix 7. ERIC (CSA) search strategy
(KW=(computer mediated communication* or electronic mail* or email* or e-mail* or web mail* or webmail* or internet mail* or
mailing list* or discussion list* or listserv*) or KW=((patient or health or information or web or internet) within 1 portal*) or KW=
(patient within 1 (web* or internet)) or KW=((web* or internet or www or electronic* or online or on-line) within 5 (messag* or
communicat* or transmi* or transfer* or send* or deliver* or feedback or letter* or interactiv* or input* or forum or appointment* or
booking* or schedul* or remind* or referral* or consult* or prescri*)) or KW=((online or on-line or web* or internet) within 4 (service*
or intervention* or therap* or treatment* or counsel*)) or KW=(e-communication* or e-consult* or e-visit* or e-referral* or e-booking*
or e-prescri*)) and (KW=(health* or medic* or patient* or clinic* or hospital* or illness* or disease* or disorder* or therap* or physician*
or doctor* or psychotherap* or psychiatr* or telemedic* or treatment* or consult* or counsel* or referral* or remind* or appointment*
or booking* or schedul* or visit* or prescri* or promot* or prevent* or diagnos* or test result* or screen* or intervention* or care))
and (KW=(random* or trial* or placebo* or assign* or allocat* or volunteer* or crossover or cross over or factorial* or singl* blind* or
doubl* blind* or clinical stud* or longitudinal stud* or control* or compar* or intervention* or preintervention or postintervention or
pre test or pretest or post test or posttest or experiment* or prospectiv* or chang* or evaluat* or impact* or effect* or time series))
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Wemade changes to the Background section of the review since the protocol was published (Meyer 2009), to update the cited literature.
We had stated in the protocol that the following databases would be searched as part of the grey literature search:
• Dissertation Abstracts (North American and European theses) via British Library
• TrialsCentralTM (www.trialscentral.org)
We did not search these databases, and this decision was made in conjunction with the Cochrane Consumers and Communication
Review Group. TrialsCentral TM pulled in information from sources already used in the grey literature search. The only search options
were to search by condition or intervention for clinical and drug interventions only (no free text). Dissertation Abstracts was not
searched as several of the other databases would duplicate this search (Index to Theses, ProQuest).
MEDLINE search: Minor changes have been made to the MEDLINE strategy since the protocol stage (Meyer 2009). The new version
of the search can be found in Appendix 3 of the review. These changes were made in conjunction with the Review Group’s Trials Search
Coordinator, John Kis-Rigo. The changes involve the removal of the term ’on-line’ from the strategy. This is because Ovid MEDLINE
changed the way it processed this term, and we were retrieving a very high number of articles (20,000+), whereas before the change in
processing we had obtained around 8000. Removing this term brought the retrieval rate back down to acceptable levels.
Data synthesis: Minor changes made to the wording of this section for clarity.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Diagnosis; ∗Electronic Mail; ∗Telephone; ∗Text Messaging
MeSH check words
Humans
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